Total Payments
$229.81
2019 Payments
$81.23
Companies
5
Transactions
14
Medicare Patients
1,847
Medicare Billing
$333,781
Payment Breakdown by Category
Food & Beverage$229.81 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $229.81 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $134.77 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $38.60 | 2 | $0 (2019) |
| PFIZER INC. | $24.36 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $17.81 | 1 | $0 (2017) |
| Amgen Inc. | $14.27 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $81.23 | 4 | Novartis Pharmaceuticals Corporation ($38.60) |
| 2018 | $49.11 | 4 | Janssen Pharmaceuticals, Inc ($24.75) |
| 2017 | $99.47 | 6 | Janssen Pharmaceuticals, Inc ($81.66) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Bone Health | ||||||
| 05/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/29/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DIABETES | ||||||
| 03/02/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 383 | 1,188 | $100,715 | $67,884 |
| 2022 | 4 | 446 | 1,607 | $131,082 | $87,622 |
| 2021 | 4 | 411 | 1,523 | $120,347 | $81,832 |
| 2020 | 9 | 607 | 1,964 | $150,980 | $96,443 |
Total Patients
1,847
Total Services
6,282
Medicare Billing
$333,781
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 668 | $53,186 | $35,516 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 325 | $38,191 | $25,801 | 67.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 91 | 179 | $8,492 | $5,945 | 70.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 16 | $846.40 | $622.49 | 73.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 1,119 | $89,095 | $57,600 | 64.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 274 | $32,198 | $23,768 | 73.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 111 | 200 | $9,488 | $6,015 | 63.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 14 | $301.84 | $238.72 | 79.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 234 | 1,246 | $99,207 | $67,296 | 67.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 113 | $13,279 | $9,376 | 70.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 97 | 149 | $7,069 | $4,615 | 65.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 14 | 15 | $793.50 | $545.22 | 68.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 276 | 1,432 | $114,016 | $74,057 | 65.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 159 | $18,684 | $10,057 | 53.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 74 | 92 | $4,364 | $3,142 | 72.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 48 | $3,823 | $2,711 | 70.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 15 | $3,346 | $2,064 | 61.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 83 | 119 | $2,566 | $1,800 | 70.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 23 | 29 | $1,534 | $1,172 | 76.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 15 | 16 | $1,275 | $933.44 | 73.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 54 | $1,372 | $507.31 | 37.0% |
About Daniel Mcgrane, M.D., P.A
Daniel Mcgrane, M.D., P.A is a Specialist healthcare provider based in Zephyrhills, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356358972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Mcgrane, M.D., P.A has received a total of $229.81 in payments from pharmaceutical and medical device companies, with $81.23 received in 2019. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($229.81).
As a Medicare-enrolled provider, Mcgrane has provided services to 1,847 Medicare beneficiaries, totaling 6,282 services with total Medicare billing of $333,781. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Zephyrhills, FL
- Active Since 08/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356358972
Products in Payments
- XARELTO (Drug) $120.31
- ENTRESTO (Drug) $38.60
- CHANTIX (Drug) $24.36
- TOUJEO (Drug) $17.81
- INVOKANA (Drug) $14.46
- EVENITY (Biological) $14.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Zephyrhills
Dr. Moethu Win, M.d, M.D
Specialist — Payments: $15,573
Specialist $15,573
Dr. Ghazanfar Khadim, M.d, M.D
Specialist — Payments: $13,358
Specialist $13,358
Ramanath Rao, M.d, M.D
Specialist — Payments: $5,656
Specialist $5,656
Manjul Derasari
Specialist — Payments: $2,854
Specialist $2,854
Ram Batra, Md, MD
Specialist
Specialist
Laureen Houts
Specialist
Specialist